AU2020902233A0 - Peptides and uses thereof - Google Patents

Peptides and uses thereof

Info

Publication number
AU2020902233A0
AU2020902233A0 AU2020902233A AU2020902233A AU2020902233A0 AU 2020902233 A0 AU2020902233 A0 AU 2020902233A0 AU 2020902233 A AU2020902233 A AU 2020902233A AU 2020902233 A AU2020902233 A AU 2020902233A AU 2020902233 A0 AU2020902233 A0 AU 2020902233A0
Authority
AU
Australia
Prior art keywords
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020902233A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Preveceutical Medical Inc
Original Assignee
Preveceutical Medical Inc
Filing date
Publication date
Application filed by Preveceutical Medical Inc filed Critical Preveceutical Medical Inc
Publication of AU2020902233A0 publication Critical patent/AU2020902233A0/en
Priority to PCT/AU2021/050707 priority Critical patent/WO2022000043A1/en
Priority to CA3188556A priority patent/CA3188556A1/en
Priority to EP21832508.2A priority patent/EP4175970A4/en
Priority to US18/003,768 priority patent/US20240301023A1/en
Priority to AU2021300202A priority patent/AU2021300202A1/en
Abandoned legal-status Critical Current

Links

AU2020902233A 2020-07-01 2020-07-01 Peptides and uses thereof Abandoned AU2020902233A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/AU2021/050707 WO2022000043A1 (en) 2020-07-01 2021-07-01 Peptides and uses thereof
CA3188556A CA3188556A1 (en) 2020-07-01 2021-07-01 Peptides and uses thereof
EP21832508.2A EP4175970A4 (en) 2020-07-01 2021-07-01 Peptides and uses thereof
US18/003,768 US20240301023A1 (en) 2020-07-01 2021-07-01 Peptides and uses thereof
AU2021300202A AU2021300202A1 (en) 2020-07-01 2021-07-01 Peptides and uses thereof

Publications (1)

Publication Number Publication Date
AU2020902233A0 true AU2020902233A0 (en) 2020-07-16

Family

ID=

Similar Documents

Publication Publication Date Title
EP4096712A4 (en) Deoptimized sars-cov-2 and methods and uses thereof
EP4076448A4 (en) Fluoroalkyl-oxadiazoles and uses thereof
EP4069274A4 (en) Peptide conjugates and methods of use
EP4121031A4 (en) 3-diarylmethylenes and uses thereof
EP3740228A4 (en) Peptides and uses thereof
EP3882263A4 (en) Glucagon-derived peptide and use thereof
EP4190802A4 (en) Cell-penetrating peptide and use thereof
EP4003391A4 (en) Peptides and methods of using the same
EP4141020A4 (en) Novel cell-penetrating peptide and use thereof
AU2020234373A1 (en) Novel peptide and use thereof
EP4004021A4 (en) Polypeptides having anti-senescent effects and uses thereof
EP3952988A4 (en) Aav-cas13d vectors and uses thereof
EP3996737A4 (en) Peptides and uses thereof
EP4132554A4 (en) Anti-obesity peptides and uses thereof
EP4175970A4 (en) Peptides and uses thereof
EP3984595A4 (en) Peptide and use thereof
EP3976630A4 (en) Actrii-binding proteins and uses thereof
EP4023663A4 (en) Polypeptide and application thereof
EP4114477A4 (en) Mechanoactive materials and uses thereof
AU2021903722A0 (en) Peptides and Uses Thereof
AU2020904544A0 (en) Peptides and uses thereof
AU2020904375A0 (en) Peptides and uses thereof
EP4103586A4 (en) Polypeptides and their use
AU2020902233A0 (en) Peptides and uses thereof
EP3966201A4 (en) Thiosemicarbazates and uses thereof